Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-53295

ABSTRACT: Transcription profiling by arrayof HCT116 cells after stimulation with oncostatin M (OSM) against untreated controls to study the role of OSM in intestinal inflammation

PROVIDER: E-GEOD-53295 | ExpressionAtlas | 2015-01-05

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

Gene expression of HCT116 cells after stimulation with oncostatin M (OSM)

Project description:To evaluate gene expression profiles in intestinal epithelial cells (IEC) after OSM stimulation, we have employed whole genome microarray expression profiling as a discovery platform to identify relevant genes which are potentially of interest to reveal the role of OSM in intestinal inflammation. The most strongly up-regulated genes were SERPINS, which belong to the family of serin peptidase inhibitors with antiprotease activities, most of them serine and cysteine proteases. SERPINB4, SERPINB3 and SERPINA3 were the genes with the strongest up-regulation, also verified in qPCR. OSM-induced SERPIN up-regulation may contribute to anti-apoptotic and proliferative effects of OSM in IEC. HCT116 cells were starved overnight with medium containing 1% FCS after reaching 70% confluency. On the next day, cells were stimulated in quadruplicates with 100 ng/mL OSM or left unstimulated. RNA was isolated 6 hours after stimulation and RNA concentration and purity was measured.

2014-12-13 | E-GEOD-53295 | biostudies-arrayexpress

The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [whole cell RNA]

Project description:To elucidate whether Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of ETBF treated HCT116 colorectal cancer cell lines.

2023-11-08 | GSE161047 | GEO

The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes]

2023-11-08 | GSE161048 | GEO

H2O2-treated and untreated HCT116 cells

Project description:H2O2-treated and untreated HCT116 cells

| PRJNA305862 | ENA

RNA-seq of H929 cells treated with Solamargine against untreated controls

Project description:RNA-seq of H929 cells treated with Solamargine against untreated controls

| PRJEB46862 | ENA

Pseudomonas aeruginosa treated with UV against untreated controls

Project description:Pseudomonas aeruginosa treated with UV against untreated controls

| PRJEB40577 | ENA

Murine small intestinal crypt cell line IEC-6: control vs. TGF-beta stimulated

Project description:microRNA profiling of rat small intestinal crypt cell IEC-6. Comparing control untreated with cells treated with transforming growth factor-beta (TGF-beta). TGF-beta stimulated cell differentiation, as observed in the stimulation of intestinal epithelial cell markers (alkaline phophotase, villin, aminopeptidase N, etc.).

2012-06-19 | GSE20982 | GEO

RNA-Seq of human aortic endothelial cells with lysophosphatidylinositol against untreated controls

Project description:RNA-Seq of human aortic endothelial cells with lysophosphatidylinositol against untreated controls

| PRJEB25610 | ENA

RNA-Seq of human aortic endothelial cells with lysophosphatidylcholine against untreated controls

Project description:RNA-Seq of human aortic endothelial cells with lysophosphatidylcholine against untreated controls

| PRJEB25611 | ENA

Immunoglobulin V-gene usage among human serum IgA with or without specificity to the autoantigen transglutaminase 2

Project description:To study V-gene usage among antigen-specific and non-antigen-specific serum IgA antibodies in celiac disease patients, purified antibody fractions were subjected to proteomic analysis. Patients either had eastablished, untreated disease with severe intestinal inflammation or "potential" celiac disease characterized by presence of antibodies but no or mild inflammation. Quantification of the fraction of antibodies using different IGHV segments revealed that antibodies specific to the autoantigen transglutaminase 2 (TG2) displayed a bias toward usage of IGHV5-51 in agreement with previous observations. The fraction of antibodies using IGHV5-51 correlated with the degree of intestinal inflammation, indicating that production of hallmark IGHV5-51 anti-TG2 antibodies coincides with onset of clinical celiac disease.

2019-07-09 | PXD013777 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data